H Tilly
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 20
- Genetics 14
- Chronic Lymphocytic Leukemia Research 13
- Co-authors
- Corinne Haïoun (8 shared papers)F Reyes (4 shared papers)John Radford (2 shared papers)Renaud Capdeville (1 shared paper)Nicolas Ketterer (1 shared paper)Dengyan Ma (1 shared paper)Volker Diehl (1 shared paper)Peter Johnson (1 shared paper)
In The Last Decade
H Tilly
43 papers receiving 1.9k citations
H Tilly's Hit Papers
Peers
Comparison fields: 5 of 73
- Pathology and Forensic Medicine 1.3k
- Genetics 674
- Hematology 460
- Oncology 856
- Neurology 350
Countries citing papers authored by H Tilly
This map shows the geographic impact of H Tilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Tilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Tilly more than expected).
Fields of papers citing papers by H Tilly
This network shows the impact of papers produced by H Tilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Tilly. The network helps show where H Tilly may publish in the future.
Co-authors
The 25 scholars most cited alongside H Tilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Hit paper breakdown → | 1998 | 724 |
| 2 | 1989 | 213 | |
| 3 | 1992 | 177 | |
| 4 | 1997 | 162 | |
| 5 | 1996 | 127 | |
| 6 | 1993 | 126 | |
| 7 | 1992 | 79 | |
| 8 | 2002 | 56 | |
| 9 | 2000 | 54 | |
| 10 | 1997 | 50 | |
| 11 | 1991 | 44 | |
| 12 | 1994 | 24 | |
| 13 | 1993 | 18 | |
| 14 | 2005 | 17 | |
| 15 | 2009 | 16 | |
| 16 | Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1. | 1991 | 16 |
| 17 | 2021 | 13 | |
| 18 | 1999 | 11 | |
| 19 | びまん性大細胞型B細胞非Hodgkinリンパ腫 診断,治療および追跡のためのESMO診療ガイドライン | 2010 | 8 |
| 20 | 2006 | 7 |
About H Tilly
H Tilly is a scholar working on Pathology and Forensic Medicine, Genetics, Hematology, Molecular Biology and Oncology, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Viral-associated cancers and disorders (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.3k citations), Genetics (674 citations), Hematology (460 citations), Oncology (856 citations) and Neurology (350 citations). H Tilly has collaborated with scholars based in France, Belgium and Czechia. Frequent co-authors include Corinne Haïoun, F Reyes, John Radford, Renaud Capdeville, Nicolas Ketterer, Dengyan Ma, Volker Diehl, Peter Johnson, Michaela Feuring Buske and Andreas Engert. Their work appears in journals such as Journal of Clinical Oncology, Blood, Leukemia, Annals of Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.